Eris Biotech: A Biotech Model Developing Small-Molecule Drugs in Cancer Immunotherapy
An analysis of the business model of Eris Biotech, a biotech company researching small molecules that act on how tumors evade the immune system, based on an earlier Think & Rich article; figures and events are unverified.
Think & Rich